Organization
Ege University Medical Faculty
2 abstracts
Abstract
First-line lenvatinib + pembrolizumab treatment across non-clear cell renal cell carcinomas: Results of the phase 2 KEYNOTE-B61 study.Org: Memorial Sloan Kettering Cancer Center, Macquarie University, Volga District Medical Center, Federal Medical-Biological Agency, Medical Oncology Group,
Abstract
A CASE REPORT, MESENTERIC BUERGER'S DISEASEOrg: Internal Medicine Residency, Ege University Medical Faculty, Rheumatology, Radiology and Nuclear Medicine Unit, Morgagni-Pierantoni Hospital, Forli, Italy, Ege University Medical School,